Tibetan Medicine for Diabetes Mellitus: Overview of Pharmacological Perspectives

Tibetan Medicine for Diabetes Mellitus: Overview of Pharmacological Perspectives

Diabetes mellitus (DM) and its complications pose a major public health threat which is approaching epidemic proportions globally. Current drug options may not provide good efficacy and even cause serious adverse effects. Seeking safe and effective agents for DM treatment has been an area of intensi...

Full description

Bibliographic Details
Main Authors:	Li-Shan Yan, Brian Chi-Yan Cheng, Shuo-Feng Zhang, Gan Luo, Chao Zhang, Qing-Gao Wang, Xiu-Qiong Fu, Yi-Wei Wang, Yi Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-10-01
Series:	Frontiers in Pharmacology
Subjects:	tibetan material medica diabetes mellitus insulin resistance diabetic complications pharmacology
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.748500/full

Similar Items

A Review on the Ethnomedicinal Usage, Phytochemistry, and Pharmacological Properties of Gentianeae (Gentianaceae) in Tibetan Medicine
by: Xiaofeng Chi, et al.
Published: (2021-11-01)

Catalpol in Diabetes and its Complications: A Review of Pharmacology, Pharmacokinetics, and Safety
by: Ying Bai, et al.
Published: (2019-09-01)

A comprehensive review of Shengdeng in Tibetan medicine: textual research, herbal and botanical distribution, traditional uses, phytochemistry, and pharmacology
by: Jing Ma, et al.
Published: (2023-12-01)

The transcriptomic and epigenetic alterations in type 2 diabetes mellitus patients of Chinese Tibetan and Han populations
by: Xian Wang, et al.
Published: (2023-02-01)

Integrated biomarker profiling of the metabolome associated with type 2 diabetes mellitus among Tibetan in China
by: Jinli Meng, et al.
Published: (2023-07-01)

The Tibetan Antelope Population Depends on Lakes on the Tibetan Plateau
by: Li Zhang, et al.
Published: (2023-11-01)

Diabetes mellitus: From molecular mechanism to pathophysiology and pharmacology
by: Oluwafemi Adeleke Ojo, et al.
Published: (2023-09-01)

Breef overview of gestational diabetes mellitus
by: Madalina-Ioana Melestean-Bratu, et al.
Published: (2022-09-01)

The Potential Roles of Artemisinin and Its Derivatives in the Treatment of Type 2 Diabetes Mellitus
by: Ya-yi Jiang, et al.
Published: (2020-11-01)

Progress on the pathogenesis of cardiovascular complications in patients with type 2 diabetes mellitus
by: ZHENG Tian-sheng, TONG Xue-wei, ZHANG Yi-tong, ZHU Min, ZHAN Xiao-rong
Published: (2022-05-01)

Epidemical survey of relative factors of retinal vessels disease of the native Tibetan among the people aged 40 and above in Maqin county, Qinghai province
by: Peng-Cheng Wu, et al.
Published: (2014-07-01)

System Pharmacology-Based Dissection of the Synergistic Mechanism of Huangqi and Huanglian for Diabetes Mellitus
by: Shi-Jun Yue, et al.
Published: (2017-10-01)

Introduction to Diabetes Management for Pediatric Residents
by: Katherine Stanley, et al.
Published: (2015-08-01)

Protective Effects of Medicinal Plant-Based Foods against Diabetes: A Review on Pharmacology, Phytochemistry, and Molecular Mechanisms
by: Prawej Ansari, et al.
Published: (2023-07-01)

Efficacy Evaluation Study for Microburst Insulin Infusion: A Novel Model of Care
by: Steven W. Howard, et al.
Published: (2021-08-01)

Relationship between the early initiation of insulin treatment and diabetic complications in patients newly diagnosed with type 2 diabetes mellitus in Korea: A nationwide cohort study
by: Ha‐Lim Jeon, et al.
Published: (2022-05-01)

Mechanism of Tibetan medicine Terminalia Chebula Retz in rheumatoid arthritis: a study based on network pharmacology
by: LIU Fang, et al.
Published: (2019-11-01)

Diabetes Mellitus and Cause-Specific Mortality: A Population-Based Study
by: Sen Li, et al.
Published: (2019-06-01)

Overview of Sino-Tibetan morphosyntax
by: LaPolla, Randy J.
Published: (2021)

Network pharmacological analysis of ethanol extract of Morus alba linne in the treatment of type 2 diabetes mellitus
by: Jia-Wei Tang, et al.
Published: (2021-10-01)

Randomised prospective study for the effect of therapy on residual beta cell function in type-1 diabetes mellitus [ISRCTN70703138]
by: Bretzel Reinhard G, et al.
Published: (2003-12-01)

Network pharmacology-based screening of the active ingredients and mechanisms of Cymbaria daurica against diabetes mellitus
by: Ruyu Shi, et al.
Published: (2023-11-01)

Dataset of materia medica in Sowa Rigpa: Tibetan medicine botanicals and Gawé Dorjé’s classification system
by: Rigdzin Wangyal, et al.
Published: (2020-12-01)

Prevalence of Anaemia in Patients with Type-2 Diabetes Mellitus in the Absence of Renal Impairment: A Cross-sectional Study
by: Sandeep S Reddy, et al.
Published: (2021-09-01)

Constitution of a comprehensive phytochemical profile and network pharmacology based investigation to decipher molecular mechanisms of Teucrium polium L. in the treatment of type 2 diabetes mellitus
by: Vahap Murat Kutluay, et al.
Published: (2020-10-01)

Research advances of correlation between apolipoprotein C3 and diabetes mellitus and diabetic kidney disease
by: Ling-zhi Li, et al.
Published: (2024-04-01)

The potential of astragalus polysaccharide for treating diabetes and its action mechanism
by: Shiyu Liu, et al.
Published: (2024-04-01)

Relation of retinopathy in patients with type 2 diabetes mellitus to other diabetic complications
by: Shu-Hui Chen, et al.
Published: (2016-02-01)

Comparison of continuous subcutaneous insulin infusion treatment and multiple daily injection treatment on the progression of diabetic complications in Japanese patients with juvenile‐onset type 1 diabetes mellitus
by: Takafumi Masuda, et al.
Published: (2022-09-01)

Evidentiality in Rgyalthang Tibetan
by: Hongladarom, Krisadawan
Published: (2024)

Network pharmacology and experimental verification reveal the mechanism of safranal against glioblastoma (GBM)
by: Xiaobing Yang, et al.
Published: (2023-09-01)

Insulin therapy does not interfere with venous endothelial function evaluation in patients with type 2 diabetes mellitus
by: Antônio Marcos Vargas da Silva, et al.
Published: (2010-01-01)

An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus
by: Mohamed Omer Mahgoub, et al.
Published: (2023-05-01)

Improving management practices and clinical outcomes in type 2 diabetes study: Prevalence of complications in people with type 2 diabetes in India
by: Ashok Kumar Das, et al.
Published: (2012-01-01)

Pharmacologically Active Phytomolecules Isolated from Traditional Antidiabetic Plants and Their Therapeutic Role for the Management of Diabetes Mellitus
by: Prawej Ansari, et al.
Published: (2022-07-01)

Signaling pathways and intervention for therapy of type 2 diabetes mellitus
by: Rong Cao, et al.
Published: (2023-06-01)

Evaluating All Potential Oral Complications of Diabetes Mellitus
by: Martijn J. L. Verhulst, et al.
Published: (2019-02-01)

Factors influencing the severity of COVID-19 course for patients with diabetes mellitus in tashkent: a retrospective cohort study
by: A. V. Alieva, et al.
Published: (2023-07-01)

An Integrated Approach Based on Network Pharmacology Combined with Experimental Verification Reveals AMPK/PI3K/Akt Signaling is an Important Way for the Anti-Type 2 Diabetic Activity of Silkworm Excrement
by: Duan H, et al.
Published: (2021-02-01)

Pharmacological inhibitors of β-cell dysfunction and death as therapeutics for diabetes
by: Stéphane Dalle, et al.
Published: (2023-03-01)